Name | 1-(1H-Pyrazol-1-yl)-2-propanamine |
---|---|
Synonyms |
4-Methyl-3-nitro-benzoesaeure-methylester
3-nitro-4-phenoxy-5-sulphamylbenzoic acid methyl ester methyl 3-nitro-4-phenoxy-5-sulfamoylbenzoate Methyl 3-nitro-p-toluate Methyl 3-nitro-4-methylbenzoate 3-nitro-4-phenoxy-5-sulfamoylbenzoic acid methyl ester 4-Methyl-3-nitrobenzoic acid methyl ester |
Molecular Formula | C6H11N3 |
---|---|
Molecular Weight | 125.17200 |
Exact Mass | 125.09500 |
PSA | 43.84000 |
LogP | 0.93060 |
~% 57939-04-5 |
Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; Location in patent: Page/Page column 111 ; WO 2012/018635 A2 |
~96% 57939-04-5 |
Literature: CONCERT PHARMACEUTICALS INC.; Tung, Roger Patent: US2014/128469 A1, 2014 ; Location in patent: Paragraph 0110; 0112 ; |
~% 57939-04-5 |
Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
~% 57939-04-5 |
Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |